Phage Futures 2020
Phage Futures Congress, Washington D.C., US 2020 JAFRAL is proud sponsor [...]
Evergreen International Phage Biology Meeting 2019
Evergreen International Phage Biology Meeting 2019 JAFRAL is going to be [...]
Baceriophage Therapy Summit 2019
JAFRAL is proud to be sponsoring Bacteriophage Therapy Summit that will be held 25-27th of March 2019 in Boston, US.
The Phage Futures Congress 2019
JAFRAL is going to attend The Phage Futures 2019 in Washington, [...]
Gene therapy IL-12 clinical trial
JAFRAL is proud to be a GMP manufacturing partner of a consortium/project for first clinical trial on combined electrochemotherapy with gene therapy with Interleukin-12 (IL-12) to improve/enhance local and systemic response to skin tumor treatment.
Competence Center Bio-Pharm
As of June 1 2018 JAFRAL is a part of Bio-Pharm Competence Center for Biotechnology and Pharmaceuticals.
WHO: World is running out of antibiotics
On 20th September 2017, WHO launched report about antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis. Report shows a